AbC-19™ Rapid Test by Abingdon Health

The AbC-19™ Rapid Test is able to confirm that IgG antibodies to the full Spike protein have been produced after vaccination or following direct exposure to the SARS-CoV-2 virus.

The AbC-19™ Rapid Test can be deployed across multiple populations and has the potential to inform vaccination programmes and health policy. The test can do this by showing how COVID-19 infection spreads through communities, where any why immunity to COVID-19 might be developing and how mass-immunisation campaigns could be designed.

The AbC-19™ Rapid Test is delivered at point of care (POC) using a blood sample from a finger-stick puncture, with test results ready in just 20 minutes.

Why use the AbC-19™ Rapid Test?

1. Confirms the presence of SARS-CoV-2 IgG neutralising antibodies in a small blood sample
2. Sensitivity: 98.03%, Specificity: 99.56%*
3. Minimal operator training required
4. CE marked for use by healthcare professionals
5. For use in multiple testing locations such as workplaces, pharmacies or doctors’ surgeries